| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Calise Chris serves as a Director at COEP and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $5.3M at current prices.
The biggest single holding is ZSQR (~$3.9M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 | COEP Coeptis Therapeutics Holdings, Inc. | - | Buy | 11,582 | $0.94 | $10,878.56 | +0.8% | +31.5% | -77.0% |